Skip to Content

LCE 125 (Stalevo 125 31.25 mg / 200 mg / 125 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill imprint LCE 125 has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg.

Stalevo 125 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 125 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Stalevo 125 31.25 mg / 200 mg / 125 mg LCE 125
Stalevo 125 31.25 mg / 200 mg / 125 mg LCE 125
Discount Card Promo
Stalevo 125
Generic Name:
carbidopa/entacapone/levodopa
Imprint:
LCE 125
Strength:
31.25 mg / 200 mg / 125 mg
Color:
Red
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Novartis Pharmaceuticals
National Drug Code (NDC):
00078-0545
Inactive Ingredients:
corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00781-5641 Sandoz Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide